Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-01 Option Award | 2024-05-03 4:10 pm | N/A 2034-04-30 | Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO | 474,000 | $0 | 474,000 (Direct) | View |
2024-01-01 Option Award | 2024-01-03 4:15 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Russo Rene PRESIDENT AND CEO | 177,000 | $0 | 177,000 (Direct) | View |
2023-08-16 Option Award | 2023-08-18 8:45 pm | N/A 2033-08-15 | Xilio Therapeutics Inc. | XLO | Russo Rene CEO | 700,000 | $0 | 700,000 (Direct) | View |
2023-01-01 Option Award | 2023-01-04 4:14 pm | N/A 2032-12-31 | Xilio Therapeutics Inc. | XLO | Russo Rene CEO | 350,000 | $0 | 350,000 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 5:30 pm | N/A 2032-02-21 | Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT | 150,000 | $0 | 150,000 (Direct) | View |
2021-12-22 Option Award(A) | 2022-01-04 5:32 pm | N/A 2031-12-21 | Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT | 100,000 | $0 | 100,000 (Direct) | View |
2021-12-22 Option Award | 2021-12-23 7:06 pm | N/A 2031-12-21 | Xilio Therapeutics Inc. | XLO | Russo Rene CEO AND PRESIDENT | 100,000 | $0 | 100,000 (Direct) | View |
2021-10-21 Option Award | 2021-10-25 5:18 pm | N/A 2031-10-20 | Xilio Therapeutics Inc. | XLO | Russo Rene CEO and President 10% Owner | 50,041 | $0 | 50,041 (Direct) | View |
Ownership | 2021-10-21 8:45 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Russo Rene CEO and President 10% Owner | 0 | $0 | 1,048,804 (Direct) | View |
2021-08-05 Option Award | 2021-08-09 7:55 pm | N/A 2031-08-04 | Adagio Therapeutics Inc. | ADGI | Russo Rene Director | 35,593 | $0 | 35,593 (Direct) | View |
Ownership | 2021-08-05 9:26 pm | N/A N/A | Adagio Therapeutics Inc. | ADGI | Russo Rene Director | 0 | $0 | 1,985,295 (Direct) | View |
2021-06-02 Option Award | 2021-06-02 4:57 pm | N/A 2031-06-02 | X4 Pharmaceuticals Inc | XFOR | Russo Rene Director | 6,000 | $9.5 | 6,000 (Direct) | View |
2020-06-10 Option Award | 2020-06-11 08:31 am | N/A 2030-06-09 | X4 Pharmaceuticals Inc | XFOR | Russo Rene Director | 3,427 | $0 | 3,427 (Direct) | View |